Earnings Feed
Start Free
SUNESIS PHARMACEUTICALS INC·4

Jul 3, 7:39 PM ET

Misfeldt Dayton 4

4 · SUNESIS PHARMACEUTICALS INC · Filed Jul 3, 2018

Insider Transaction Report

Form 4
Period: 2018-06-29
SUNESIS PHARMACEUTICALS INCSNSS
Misfeldt Dayton
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-29+200,000→ 200,000 total
    Exercise: $2.12Exp: 2028-06-29→ Common Stock (200,000 underlying)
  • Award

    Stock Option(Right to Buy)

    2018-06-29+25,000→ 25,000 total
    Exercise: $2.12Exp: 2028-06-29→ Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]The option vests monthly over six (6) months from the date of grant subject to the optionee's continued service to the Company.
  • [F2]The option shall vest and become exercisable in twelve (12)equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.

Documents

2 files